When to Order Imaging for Staging and Surveillance of Testicular Cancer: ACR Appropriateness Decoded
A 25-year-old male is in your clinic, one week post-orchiectomy for a newly diagnosed testicular germ cell tumor. The pathology is back, and now you need to determine the extent of disease to guide further management. Do you order a CT of the abdomen and pelvis, or should you consider an MRI to limit radiation exposure in this young patient? What about chest imaging? For a cancer with a high cure rate, choosing the right initial staging and subsequent surveillance imaging is critical for balancing diagnostic accuracy with long-term risks. This guide decodes the American College of Radiology (ACR) Appropriateness Criteria to help you make evidence-based decisions.
What Does ACR Staging and Surveillance of Testicular Cancer Cover?
This ACR Appropriateness Criteria document focuses specifically on the imaging workup for patients with a pathologically confirmed diagnosis of testicular cancer following orchiectomy. The guidance is structured around two key clinical phases: initial staging and ongoing surveillance for recurrence. The recommendations are further stratified by the primary histology—pure seminoma versus nonseminomatous germ cell tumors (NSGCT)—as their patterns of spread and response to therapy can differ. This document addresses common clinical scenarios, including routine surveillance in asymptomatic, low-stage disease and the evaluation of a patient with a clinical or biochemical suspicion of recurrence. It does not cover the initial diagnostic evaluation of a scrotal mass, for which ultrasound is the primary modality, nor does it detail imaging for advanced, metastatic disease beyond the initial staging workup.
What Imaging Should I Order for Staging and Surveillance of Testicular Cancer? Recommendations by Clinical Scenario
The choice of imaging for testicular cancer depends on the histology and clinical context—whether for initial staging or surveillance. The ACR provides clear, evidence-based recommendations for these common situations.
For the initial staging of both pure seminoma and nonseminoma testicular cancer after diagnosis by orchiectomy, CT of the abdomen and pelvis with IV contrast is rated Usually appropriate. This is the workhorse study for identifying retroperitoneal lymphadenopathy, the most common site of initial metastasis. As a non-ionizing alternative, MRI of the abdomen and pelvis without and with IV contrast is also rated Usually appropriate and is a key consideration for reducing cumulative radiation dose. For thoracic evaluation, a simple Radiography chest is also Usually appropriate as a baseline screen for pulmonary metastases. For nonseminoma, which has a higher propensity for lung metastases, CT chest with IV contrast is also considered Usually appropriate.
In the context of surveillance of stage IA and IB pure seminoma or nonseminoma with no clinical suspicion of recurrence, the recommendations are similar. CT abdomen and pelvis with IV contrast remains Usually appropriate, though the frequency of its use is often debated to minimize radiation. MRI abdomen and pelvis without and with IV contrast is an equally appropriate alternative. A Radiography chest is also Usually appropriate for monitoring the lungs. The goal in surveillance is to detect recurrence early while adhering to the As Low As Reasonably Achievable (ALARA) principle for radiation.
When there is a suspected recurrence of either seminoma or nonseminoma (e.g., rising tumor markers or palpable adenopathy), a more comprehensive imaging evaluation is warranted. Both CT chest with IV contrast and CT abdomen and pelvis with IV contrast are rated Usually appropriate to identify the location and extent of disease. MRI of the abdomen and pelvis without and with IV contrast is also Usually appropriate. In this specific scenario, FDG-PET/CT whole body becomes May be appropriate, particularly for evaluating residual masses after chemotherapy in seminoma patients to differentiate viable tumor from fibrosis.
For detailed procedural information on one of the most commonly ordered studies, see our guide on CT Chest/Abdomen/Pelvis with IV Contrast.
ACR Imaging Recommendations Table
| Clinical Scenario | Top Procedure | ACR Rating | Adult RRL | Pediatric RRL |
|---|---|---|---|---|
| Initial staging of pure seminoma testicular cancer. Diagnosed by orchiectomy. | CT abdomen and pelvis with IV contrast | Usually appropriate | ☢ ☢ ☢ 1-10 mSv | ☢ ☢ ☢ ☢ 3-10 mSv [ped] |
| Initial staging of nonseminoma testicular cancer. Diagnosed by orchiectomy. | CT abdomen and pelvis with IV contrast | Usually appropriate | ☢ ☢ ☢ 1-10 mSv | ☢ ☢ ☢ ☢ 3-10 mSv [ped] |
| Surveillance of stage IA and IB pure seminoma testicular cancer. Diagnosed by orchiectomy. No clinical suspicion of recurrence. | CT abdomen and pelvis with IV contrast | Usually appropriate | ☢ ☢ ☢ 1-10 mSv | ☢ ☢ ☢ ☢ 3-10 mSv [ped] |
| Surveillance of stage IA and IB nonseminoma testicular cancer. Diagnosed by orchiectomy. No clinical suspicion of recurrence. | CT abdomen and pelvis with IV contrast | Usually appropriate | ☢ ☢ ☢ 1-10 mSv | ☢ ☢ ☢ ☢ 3-10 mSv [ped] |
| Surveillance of stage IA and IB pure seminoma and nonseminoma testicular cancer. Diagnosed by orchiectomy. Suspected recurrence. | CT abdomen and pelvis with IV contrast | Usually appropriate | ☢ ☢ ☢ 1-10 mSv | ☢ ☢ ☢ ☢ 3-10 mSv [ped] |
Adult vs. Pediatric Staging and Surveillance of Testicular Cancer Imaging: Radiation Dose Tradeoffs
Testicular cancer predominantly affects adolescents and young adults, making long-term effects of radiation exposure a significant clinical consideration. The ACR guidelines reflect this by providing distinct relative radiation level (RRL) estimates for adult and pediatric populations. While the recommended studies are generally the same, the emphasis on the ALARA principle is heightened in younger patients. The designation of MRI as Usually appropriate for abdominopelvic staging and surveillance provides a crucial radiation-free alternative to CT. Clinicians must weigh the benefits of CT—speed, widespread availability, and established protocols—against the cumulative radiation dose from repeated surveillance scans over many years. For pediatric patients, protocols should be specifically tailored to reduce dose, and the threshold for choosing a non-ionizing modality like MRI may be lower. Discussing these tradeoffs with patients and their families is an important part of shared decision-making in long-term cancer survivorship care.
Imaging Protocol Details for Staging and Surveillance of Testicular Cancer
Once you’ve decided on the right study based on the clinical scenario, ensuring it is performed correctly is the next critical step. The right protocol, contrast timing, and field of view are essential for diagnostic accuracy. Our protocol guides provide detailed, practical information for the studies recommended in these ACR criteria.
Tools to Help You Order the Right Study
Navigating imaging guidelines can be complex. GigHz offers a suite of free reference tools designed to support clinical decision-making at the point of care, helping you select the most appropriate study and understand its implications.
The Imaging Appropriateness Selector provides direct access to the full, searchable ACR guidelines. For clinical questions beyond testicular cancer, this tool can help you find evidence-based recommendations for thousands of clinical scenarios, ensuring your imaging orders are always justified.
Our Imaging Protocol Library is a resource for understanding the technical details of specific studies. After choosing a modality, you can review standard protocols, contrast requirements, and other key parameters to ensure the exam is optimized to answer the clinical question.
The Radiation Dose Calculator is an essential tool for communicating with patients about the risks and benefits of medical imaging. It helps estimate cumulative radiation exposure from various studies, facilitating informed discussions, particularly with young cancer patients undergoing long-term surveillance.
Why is CT often used for testicular cancer staging instead of MRI, given the radiation risk?
CT is frequently used due to its rapid acquisition time, high spatial resolution for detecting small retroperitoneal nodes, widespread availability, and lower cost compared to MRI. Radiologists and oncologists have extensive experience with CT for this indication, and it is well-validated in clinical trials. While MRI is an excellent radiation-free alternative, it can be more susceptible to motion artifact and may be less available in some centers, especially for urgent evaluation.
Is FDG-PET/CT recommended for the initial staging of testicular cancer?
No, for initial staging of either seminoma or nonseminoma, FDG-PET/CT is rated Usually not appropriate by the ACR. Its primary role is in specific post-treatment scenarios, such as evaluating a residual mass after chemotherapy for seminoma to determine if it represents a viable tumor or scar tissue. For routine staging, CT or MRI provides the necessary anatomic detail.
What is the role of a chest X-ray in staging and surveillance?
A chest X-ray is rated Usually appropriate as a low-cost, very low-radiation dose method to screen for pulmonary metastases. While less sensitive than a chest CT, it is often sufficient for initial staging and routine surveillance in low-risk disease. A chest CT may be preferred for initial staging in nonseminoma, which has a higher likelihood of lung involvement, or if the chest X-ray is abnormal or equivocal.
Why isn’t scrotal ultrasound used for staging or surveillance?
Scrotal ultrasound is the definitive imaging modality for the initial diagnosis of a testicular mass. However, its role ends there. It cannot visualize the retroperitoneal lymph nodes, liver, lungs, or other common sites of metastasis. Therefore, for staging (evaluating the spread of cancer) and surveillance (monitoring for recurrence), cross-sectional imaging like CT or MRI is required.
When should a brain MRI be ordered for a patient with testicular cancer?
A brain MRI is not a routine part of the staging or surveillance workup. It is rated May be appropriate for initial staging but should be reserved for patients who present with specific neurologic signs or symptoms concerning for central nervous system (CNS) metastases. Brain metastases are uncommon at initial presentation, particularly in low-stage disease.
Frequently Asked Questions
Why is CT often used for testicular cancer staging instead of MRI, given the radiation risk?
CT is frequently used due to its rapid acquisition time, high spatial resolution for detecting small retroperitoneal nodes, widespread availability, and lower cost compared to MRI. Radiologists and oncologists have extensive experience with CT for this indication, and it is well-validated in clinical trials. While MRI is an excellent radiation-free alternative, it can be more susceptible to motion artifact and may be less available in some centers, especially for urgent evaluation.
Is FDG-PET/CT recommended for the initial staging of testicular cancer?
No, for initial staging of either seminoma or nonseminoma, FDG-PET/CT is rated Usually not appropriate by the ACR. Its primary role is in specific post-treatment scenarios, such as evaluating a residual mass after chemotherapy for seminoma to determine if it represents a viable tumor or scar tissue. For routine staging, CT or MRI provides the necessary anatomic detail.
What is the role of a chest X-ray in staging and surveillance?
A chest X-ray is rated Usually appropriate as a low-cost, very low-radiation dose method to screen for pulmonary metastases. While less sensitive than a chest CT, it is often sufficient for initial staging and routine surveillance in low-risk disease. A chest CT may be preferred for initial staging in nonseminoma, which has a higher likelihood of lung involvement, or if the chest X-ray is abnormal or equivocal.
Why isn’t scrotal ultrasound used for staging or surveillance?
Scrotal ultrasound is the definitive imaging modality for the initial diagnosis of a testicular mass. However, its role ends there. It cannot visualize the retroperitoneal lymph nodes, liver, lungs, or other common sites of metastasis. Therefore, for staging (evaluating the spread of cancer) and surveillance (monitoring for recurrence), cross-sectional imaging like CT or MRI is required.
When should a brain MRI be ordered for a patient with testicular cancer?
A brain MRI is not a routine part of the staging or surveillance workup. It is rated May be appropriate for initial staging but should be reserved for patients who present with specific neurologic signs or symptoms concerning for central nervous system (CNS) metastases. Brain metastases are uncommon at initial presentation, particularly in low-stage disease.
Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 26, 2026
